|
|
- 2017
High-Dose (2.5 mg) Intravitreal Bevacizumab as Rescue Therapy for Persistent Postradiation Cystoid Macular EdemaDOI: 10.1159/000448719 Keywords: Tumor, Melanoma, Radiotherapy, Cystoid macular edema, Radiation damage, Anti-VEGF Abstract: To investigate the efficacy of intravitreal high-dose (2.5 mg/0.1 mL) bevacizumab as rescue therapy for postradiation cystoid macular edema (CME) resistant to standard-dose (1.25 mg/0.05 mL) bevacizumab
|
